Menu

Christine LIBON

PARIS

En résumé

Identification of new therapeutic strategies
Coordination and leadership of research project teams
Elaboration of research programs with academic teams, relations with the key opinion leaders, participation of conference organization
Project management to support mature products: coordination of pharmaceutical, toxicology, clinical and regulatory teams
Scientific expertise for external licensing opportunities
Strong skills in immunological in vitro tests and in vivo experimental models
- Vaccines
o RSV vaccine: from candidate selection to Phase III clinical sample dosages (Nguyen TN, Libon C, Stahl S. Subunit vaccine candidates engineered from the central conserved region of the RSV G protein aimed for parenteral or mucosal delivery. In Molecular Vaccines Volume 1. M Giese (Ed.) Springer-Verlag, Wien. 2013. Chapter 5 pp 104-118)
- Immunomodulation
o Alimentary supplement marketed in 2013
o Bacterial extract out licensed for a cellular immunotherapy in oncology
- Immuno-Oncology (target identification and validation)
- Inflammation : Inflammatory Bowel Diseases, dermatology, rheumatology, urology
- Autoimmune diseases (Type I diabetes, lupus)
- Biomarkers (Phases I to III): antibody responses in serum, saliva & sputum, cytokine profile on PBMC, dendritic cell maturation


Mes compétences :
Immunologie
Microsoft Word
Microsoft PowerPoint
Microsoft Excel
Respiratory syncytial virus
Vaccines
Immuno-Oncology

Entreprises

  • Labos Pierre Fabre - Responsable Pharmaco-Immunologie

    2007 - maintenant
  • Pierre Fabre - Responsable de Projet R&D

    Castres 2004 - 2007
  • Pierre Fabre - Responsable Unité Recherches & Collaborations

    Castres 2003 - 2004

Formations

Réseau

Annuaire des membres :